• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Edoxaban Noninferior to Warfarin in Atrial Fibrillation After TAVI

    ESCARDIO

    Warfarin use significantly increases risk of knee and hip replacement

    EUREKALERT

    Portola`s Announces Results Andexxa was Associated with Lowest Rate of Mortality

    PR NEWSWIRE

    XARELTO Reduced the Risk of Strokes in Nonvalvular Atrial Fibrillation

    PR NEWSWIRE

    Cereno Scientific driving thrombosis prevention without bleeding-risks

    ENDPTS

    Increased use of anti-clotting drugs tied to fewer strokes in Afib

    REUTERS

    EMA advices Armetheon to conduct single 1000 patients study for tecarfarin

    PHARMABIZ

    INRatio Blood Monitoring Device Recalled Due to Inaccurate Readings

    NEWSINFERNO

    J&J clot fighter battles Pfizer/Bristol for warfarin

    FIERCE PHARMA

    Boehringer Launches Observational Study on Management of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) with Pradaxa® (dabigatran etexilate mesylate)

    PR NEWSWIRE

    New blood thinner `antidote` to help doctors move past warfarin

    REUTERS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.